Galenica expected profit 2012: above prior-year level
Despite a tense economic situation and global pressure on healthcare costs, the Galenica Group has posted a good result…
Despite a tense economic situation and global pressure on healthcare costs, the Galenica Group has posted a good result…
Galenica's U.S. partner, Luitpold Pharmaceuticals, Inc., has received a Complete Response Letter from the US Food and Dr…
The pivotal phase III clinical study shows that the new phosphate binder PA21 successfully controls hyperphosphatemia in…
Alliance Boots and Walgreens today announced that they have entered into a strategic partnership designed to create the…
The Galenica Group posted new record results for 2011, achieving its 16th consecutive year of double-digit profit growth…
Despite the currency crisis and a difficult economic environment, the Galenica Group contin-ued to grow in 2011 and gene…
Galenica has acquired all of the outstanding shares of Vifor Uriach Pharma SL, a joint venture with its Spanish partner…
In October 2011, Galenica announced that its US partner Luitpold Pharmaceuticals, Inc. had submitted a New Drug Applicat…
The common company of Galenica and Fresenius Medical Care - Vifor Fresenius Medical Care Renal Pharma Ltd. (Vifor FMC Re…
Galenica has been strongly affected by the significant drop of both dollar and euro. While the Group generates around tw…